Refine Search
(9)
(12)
(27)
(77)

Metabolic Disorder

GlobalData provides unique and market-leading data and insights into the metabolic disorder market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Pompe Disease: Opportunity Analysis and Forecasts to 2027

  • $10,995
  • November 2018
Add to Basket Quick View Add to Saved List

Pompe disease (PD) is a rare genetic disorder resulting in the accumulation of glycogen with lysosomes in various tissues of the body. It is caused by a multitude of different phenotypical mutations to the GAA gene which is responsible for the ...

Pompe Disease: Epidemiology Forecast to 2027

  • $3,995
  • November 2018
Add to Basket Quick View Add to Saved List

Pompe disease is a rare multisystem disorder caused by pathogenic variations in the GAA gene, which contains the information for production and function of a protein called acid alpha-glucosidase (GAA). Because of the shortage of this protein (...

Obesity: Competitive Landscape to 2026

  • $3,495
  • October 2018
Add to Basket Quick View Add to Saved List

Obesity is a preventable chronic condition, defined as abnormal or excessive fat accumulation characterized by raised body mass index (BMI ≥30), which is a major risk factor for chronic diseases such as cardiovascular diseases (CVD), diabetes, ...

Abdominal Obesity Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Abdominal Obesity Global Clinical Trials Review, H2, 2018" provides an overview of Abdominal Obesity clinical trials scenario. This report provides top line data relating to the clinical trials on A...

Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2018" provides an overview of Diabetic Foot Infection (DFI) clinical trials scenario. This report provides top line data relating to ...

Amyloidosis Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H2, 2018" provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. ...

Type 1 Diabetes: Competitive Landscape to 2026

  • $3,495
  • September 2018
Add to Basket Quick View Add to Saved List

Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells of the pancreatic islet, which means that the body can no longer produce insulin. T1D can develop at any age, but is frequently observed in children and adolesc...

Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2018

  • $2,500
  • September 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Tumor Lysis Syndrome clinical trials scenario. This report provides top line data relating to the clinical trial...

Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018

  • $2,500
  • September 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Type 1 Diabetes (Juvenile Diabetes) Global Clinical Trials Review, H2, 2018" provides an overview of Type 1 Diabetes (Juvenile Diabetes) clinical trials scenario. This report provides top line data ...

Digital Landscape: Type 2 Diabetes

  • $6,000
  • August 2018
Add to Basket Quick View Add to Saved List

The Digital Landscape Type 2 Diabetes report analyzes digital activities undertaken by Pharma in support of therapies for Type 2 Diabetes (T2D).

Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2018" provides an overview of Primary Systemic Amyloidosis clinical trials scenario. This report provides top line data relating to th...

Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2018" provides an overview of Proliferative Diabetic Retinopathy (PDR) clinical trials scenario. This report provides top ...

Pompe Disease Global Clinical Trials Review, H1, 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H1, 2018" provides an overview of Pompe Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Pompe Dis...

Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2018" provides an overview of Post Menopausal Osteoporosis clinical trials scenario. This report provides top line data relating to th...

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2018" provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report provides top li...